Photo coming soon
IGF-1 LR3
Shipping and payment
Chemistry & specifications
Reference data from public databases. For research use only.
| CAS Number | Not available |
|---|---|
| Molecular Formula | Not available |
| Molecular Weight | Not available |
| Residue Count | Not available |
| Sequence (1-letter) | Not available |
| PubChem CID | Not available |
Common questions
What pack sizes and strengths are available for IGF-1 LR3?
IGF-1 LR3 is offered as a 2-vial kit, a single vial, or a 10-vial box. Available strengths: 0.1 mg and 1 mg per vial. Every vial in a kit or box is the strength you select. The price per vial for each pack is shown under the price.
How quickly does IGF-1 LR3 ship?
IGF-1 LR3 is prepared to order, so it is dispatched within 7 business days of your order. Carrier transit then takes up to 3 business days within the contiguous United States. Standard shipping is a $18.99 flat rate and free on orders over $200.
How should IGF-1 LR3 be stored?
Lyophilized (freeze-dried) vials tolerate normal shipping at room temperature. On arrival, keep them sealed, dry and away from light: a refrigerator at about 4 °C for the short term, or −20 °C or colder for long-term storage. Let a cold vial reach room temperature before opening it so moisture does not condense on the powder.
How do I work out the concentration after reconstitution?
Concentration in mg/mL equals the vial amount in mg divided by the mL of solvent added. Our free reconstitution calculator also shows the mg held at each 0.1 mL mark.
Is IGF-1 LR3 for human use?
No. IGF-1 LR3 is sold strictly for laboratory research use. It is not a drug, food, dietary supplement, or cosmetic, has not been evaluated by the FDA, and is not for human or veterinary use. Purchasers must be 21 or older.
Research background
Chemistry, identity, and a summary of the peer-reviewed literature on IGF-1 LR3.
Read the IGF-1 LR3 research background → Reconstitution calculator →Peer-reviewed research
Every research claim on this page traces to one of the 3 publications below.
- Recombinant expression of IGF-1 and LR3 IGF-1 fused with xylanase in Pichia pastorisAppl Microbiol Biotechnol (2023)View publication →
- Intranasal long R3 insulin-like growth factor-1 treatment promotes amyloid plaque remodeling in cerebral cortex but fails to preserve cognitive function in male 5XFAD miceJ Alzheimers Dis (2025)View publication →
- The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administrationFront Endocrinol (Lausanne) (2026)View publication →



